• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Heparanase is required for activation and function of macrophages.硫酸乙酰肝素酶是巨噬细胞激活和发挥功能所必需的。
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7808-E7817. doi: 10.1073/pnas.1611380113. Epub 2016 Nov 14.
2
Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth.肝素酶与化疗协同作用驱动巨噬细胞活化并增强肿瘤生长。
Cancer Res. 2020 Jan 1;80(1):57-68. doi: 10.1158/0008-5472.CAN-19-1676. Epub 2019 Nov 5.
3
Significance of host heparanase in promoting tumor growth and metastasis.宿主乙酰肝素酶在促进肿瘤生长和转移中的意义。
Matrix Biol. 2020 Nov;93:25-42. doi: 10.1016/j.matbio.2020.06.001. Epub 2020 Jun 11.
4
Heparanase: From basic research to therapeutic applications in cancer and inflammation.乙酰肝素酶:从基础研究到癌症与炎症治疗应用
Drug Resist Updat. 2016 Nov;29:54-75. doi: 10.1016/j.drup.2016.10.001. Epub 2016 Oct 6.
5
Heparanase Accelerates Obesity-Associated Breast Cancer Progression.肝素酶加速肥胖相关乳腺癌的进展。
Cancer Res. 2019 Oct 15;79(20):5342-5354. doi: 10.1158/0008-5472.CAN-18-4058. Epub 2019 Sep 3.
6
Role of heparanase 2 (Hpa2) in gastric cancer.乙酰肝素酶 2(Hpa2)在胃癌中的作用。
Neoplasia. 2021 Sep;23(9):966-978. doi: 10.1016/j.neo.2021.07.010. Epub 2021 Jul 31.
7
Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.小鼠巨噬细胞乙酰肝素酶:抑制作用及其与转移性肿瘤细胞的比较。
J Cell Physiol. 1987 Jan;130(1):77-84. doi: 10.1002/jcp.1041300112.
8
Novel function of Oncostatin M as a potent tumour-promoting agent in lung.Oncostatin M 在肺部作为一种有效的肿瘤促进剂的新功能。
Int J Cancer. 2015 Feb 15;136(4):831-43. doi: 10.1002/ijc.29055. Epub 2014 Jul 7.
9
Deletion of 5-Lipoxygenase in the Tumor Microenvironment Promotes Lung Cancer Progression and Metastasis through Regulating T Cell Recruitment.肿瘤微环境中5-脂氧合酶的缺失通过调节T细胞募集促进肺癌进展和转移。
J Immunol. 2016 Jan 15;196(2):891-901. doi: 10.4049/jimmunol.1501648. Epub 2015 Dec 11.
10
Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.刘易斯肺癌细胞促进SIGNR1(CD209b)介导的、由白细胞介素-4诱导的巨噬细胞极化,以促进免疫逃逸。
J Cell Biochem. 2016 May;117(5):1158-66. doi: 10.1002/jcb.25399. Epub 2015 Nov 2.

引用本文的文献

1
The Pathophysiological Functions of Heparanases: From Evolution, Structural and Tissue-Specific Perspectives.乙酰肝素酶的病理生理功能:从进化、结构和组织特异性角度探讨
FASEB J. 2025 Sep 15;39(17):e70976. doi: 10.1096/fj.202501859R.
2
Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localization.肿瘤源性和宿主源性乙酰肝素酶-2(Hpa2)减弱肿瘤发生能力:Hpa2在巨噬细胞极化和BRD7核定位中的作用
Cell Death Dis. 2024 Dec 18;15(12):894. doi: 10.1038/s41419-024-07262-9.
3
An integral membrane constitutively active heparanase enhances the tumor infiltration capability of NK cells.一种整合膜组成型活性乙酰肝素酶增强了自然杀伤细胞的肿瘤浸润能力。
Oncoimmunology. 2025 Dec;14(1):2437917. doi: 10.1080/2162402X.2024.2437917. Epub 2024 Dec 9.
4
Heparanase-induced endothelial glycocalyx degradation exacerbates lung ischemia/reperfusion injury in male mice.肝素酶诱导的内皮糖萼降解加剧雄性小鼠肺缺血/再灌注损伤。
Physiol Rep. 2024 Oct;12(20):e70113. doi: 10.14814/phy2.70113.
5
Analysis of Expression Pattern and Prognostic Value of the Heparanase in Breast Cancer Through CD274/CTLA-4 Immune Checkpoint Proteins.通过 CD274/CTLA-4 免疫检查点蛋白分析肝素酶在乳腺癌中的表达模式和预后价值。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241281285. doi: 10.1177/15330338241281285.
6
Design Principle of Heparanase Inhibitors: A Combined In Vitro and In Silico Study.乙酰肝素酶抑制剂的设计原理:一项体外与计算机模拟相结合的研究
ACS Med Chem Lett. 2024 May 23;15(7):1032-1040. doi: 10.1021/acsmedchemlett.3c00268. eCollection 2024 Jul 11.
7
The Uptake of Heparanase into Mast Cells Is Regulated by Its Enzymatic Activity to Degrade Heparan Sulfate.肝素酶摄取入肥大细胞受其降解肝素硫酸的酶活性调节。
Int J Mol Sci. 2024 Jun 6;25(11):6281. doi: 10.3390/ijms25116281.
8
Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis.肝素硫酸和肝素硫酸蛋白聚糖在造血中的作用。
Blood. 2024 Jun 20;143(25):2571-2587. doi: 10.1182/blood.2023022736.
9
Role of heparanase in pulmonary hypertension.乙酰肝素酶在肺动脉高压中的作用。
Front Pharmacol. 2023 Aug 11;14:1202676. doi: 10.3389/fphar.2023.1202676. eCollection 2023.
10
Heparanase-A single protein with multiple enzymatic and nonenzymatic functions.乙酰肝素酶——一种具有多种酶促和非酶促功能的单一蛋白质。
Proteoglycan Res. 2023 Jul 1;1(3):e6. doi: 10.1002/pgr2.6. Epub 2023 Jul 9.

本文引用的文献

1
Lung ICAM-1 and ICAM-2 support spontaneous intravascular effector lymphocyte entrapment but are not required for neutrophil entrapment or emigration inside endotoxin-inflamed lungs.肺细胞间黏附分子-1(ICAM-1)和ICAM-2支持效应淋巴细胞自发性血管内滞留,但对于内毒素诱发炎症的肺内中性粒细胞滞留或移出并非必需。
FASEB J. 2016 May;30(5):1767-78. doi: 10.1096/fj.201500046. Epub 2016 Jan 28.
2
A Breakthrough: Macrophage-Directed Cancer Immunotherapy.一项突破:巨噬细胞导向的癌症免疫疗法。
Cancer Res. 2016 Feb 1;76(3):513-6. doi: 10.1158/0008-5472.CAN-15-1737. Epub 2016 Jan 15.
3
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis.乙酰肝素酶中和抗体可减弱淋巴瘤肿瘤的生长和转移。
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):704-9. doi: 10.1073/pnas.1519453113. Epub 2016 Jan 4.
4
Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma.靶向硫酸乙酰肝素酶可克服骨髓瘤的化疗耐药性并减少复发。
Oncotarget. 2016 Jan 12;7(2):1598-607. doi: 10.18632/oncotarget.6408.
5
Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy.乙酰肝素酶通过促进自噬增强肿瘤生长和化疗耐药性。
Cancer Res. 2015 Sep 15;75(18):3946-57. doi: 10.1158/0008-5472.CAN-15-0037. Epub 2015 Aug 6.
6
The role of heparanase in pulmonary cell recruitment in response to an allergic but not non-allergic stimulus.肝素酶在对过敏而非非过敏刺激的肺细胞募集中的作用。
PLoS One. 2015 Jun 3;10(6):e0127032. doi: 10.1371/journal.pone.0127032. eCollection 2015.
7
Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis.紫杉醇化疗后阻断白细胞介素1β通路可轻微抑制原发性肿瘤生长,但会促进自发性转移。
Mol Cancer Ther. 2015 Jun;14(6):1385-94. doi: 10.1158/1535-7163.MCT-14-0969. Epub 2015 Apr 17.
8
Macrophage polarization in pancreatic carcinoma: role of heparanase enzyme.胰腺癌中的巨噬细胞极化:乙酰肝素酶的作用
J Natl Cancer Inst. 2014 Oct 18;106(12). doi: 10.1093/jnci/dju332. Print 2014 Dec.
9
Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.由乙酰肝素酶产生的可溶性硫酸乙酰肝素片段通过Toll样受体4(TLR-4)触发促炎细胞因子的释放。
PLoS One. 2014 Oct 8;9(10):e109596. doi: 10.1371/journal.pone.0109596. eCollection 2014.
10
The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.肝素酶和硫酸酯酶在肿瘤微环境中修饰硫酸乙酰肝素蛋白聚糖中的作用及新型癌症治疗的机会。
Front Oncol. 2014 Jul 24;4:195. doi: 10.3389/fonc.2014.00195. eCollection 2014.

硫酸乙酰肝素酶是巨噬细胞激活和发挥功能所必需的。

Heparanase is required for activation and function of macrophages.

作者信息

Gutter-Kapon Lilach, Alishekevitz Dror, Shaked Yuval, Li Jin-Ping, Aronheim Ami, Ilan Neta, Vlodavsky Israel

机构信息

Cancer and Vascular Biology Research Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel.

Department of Cell Biology and Cancer Science, Bruce Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel.

出版信息

Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7808-E7817. doi: 10.1073/pnas.1611380113. Epub 2016 Nov 14.

DOI:10.1073/pnas.1611380113
PMID:27849593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5137702/
Abstract

The emerging role of heparanase in tumor initiation, growth, metastasis, and chemoresistance is well recognized and is encouraging the development of heparanase inhibitors as anticancer drugs. Unlike the function of heparanase in cancer cells, very little attention has been given to heparanase contributed by cells composing the tumor microenvironment. Here we used a genetic approach and examined the behavior and function of macrophages isolated from wild-type (WT) and heparanase-knockout (Hpa-KO) mice. Hpa-KO macrophages express lower levels of cytokines (e.g., TNFα, IL1-β) and exhibit lower motility and phagocytic capacities. Intriguingly, inoculation of control monocytes together with Lewis lung carcinoma (LLC) cells into Hpa-KO mice resulted in nearly complete inhibition of tumor growth. In striking contrast, inoculating LLC cells together with monocytes isolated from Hpa-KO mice did not affect tumor growth, indicating that heparanase is critically required for activation and function of macrophages. Mechanistically, we describe a linear cascade by which heparanase activates Erk, p38, and JNK signaling in macrophages, leading to increased c-Fos levels and induction of cytokine expression in a manner that apparently does not require heparanase enzymatic activity. These results identify heparanase as a key mediator of macrophage activation and function in tumorigenesis and cross-talk with the tumor microenvironment.

摘要

乙酰肝素酶在肿瘤起始、生长、转移和化疗耐药中的新作用已得到充分认识,这也促使人们开发乙酰肝素酶抑制剂作为抗癌药物。与乙酰肝素酶在癌细胞中的功能不同,构成肿瘤微环境的细胞所产生的乙酰肝素酶很少受到关注。在此,我们采用遗传学方法,研究了从野生型(WT)和乙酰肝素酶基因敲除(Hpa-KO)小鼠分离出的巨噬细胞的行为和功能。Hpa-KO巨噬细胞表达较低水平的细胞因子(如TNFα、IL1-β),并且运动性和吞噬能力较低。有趣的是,将对照单核细胞与Lewis肺癌(LLC)细胞一起接种到Hpa-KO小鼠体内,几乎完全抑制了肿瘤生长。与之形成鲜明对比的是,将LLC细胞与从Hpa-KO小鼠分离出的单核细胞一起接种,并不影响肿瘤生长,这表明乙酰肝素酶对于巨噬细胞的激活和功能至关重要。从机制上来说,我们描述了一个线性级联反应,通过该反应乙酰肝素酶激活巨噬细胞中的Erk、p38和JNK信号通路,导致c-Fos水平升高,并以一种显然不需要乙酰肝素酶酶活性的方式诱导细胞因子表达。这些结果表明,乙酰肝素酶是肿瘤发生过程中巨噬细胞激活和功能以及与肿瘤微环境相互作用的关键介质。